ATR kinase inhibitor BAY1895344

From WikiMD's free health, diet & wellness encyclopedia
Jump to navigation Jump to search

An orally available ataxia telangiectasia and Rad3-related (ATR)-specific kinase inhibitor, with potential antineoplastic activity. Upon oral administration, ATR kinase inhibitor BAY1895344 selectively binds to and inhibits the activity of ATR, which prevents ATR-mediated signaling. This inhibits DNA damage checkpoint activation, disrupts DNA damage repair and induces apoptosis in ATR-overexpressing tumor cells. ATR, a serine/threonine protein kinase upregulated in a variety of cancer cell types, plays a key role in DNA repair, cell cycle progression and cell survival.

Learn more about ATR kinase inhibitor BAY1895344

Latest research - ATR kinase inhibitor BAY1895344

PubMed
Clinical trials

External links

Wikipedia
Medicine icon
Medicine icon

This WikiMD article ATR kinase inhibitor BAY1895344 is a stub. If you are familiar with the topic ATR kinase inhibitor BAY1895344, you can help us. Paid editors welcome!

 

ATR kinase inhibitor BAY1895344 is part of WikiMD's free ^articles!

^ATR kinase inhibitor BAY1895344 (article) is provided for informational purposes only. No expressed or implied warranties as to the validity of content.
WikiMD is not a substitute for professional advice. By accessing and using WikiMD you agree to the terms of use.
Templates etc. when imported from Wikipedia, are licensed under CC BY-SA 3.0. See full disclaimers.
W8MD weight loss logo

Ad. Tired of being overweight?. W8MD's physician weight loss program can HELP. Tele medicine available